Ingigerdur Solveig Sverrisdottir
Ingigerdur Solveig Sverrisdottir publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Multiple Myeloma Research and Treatments, Amyloidosis: Diagnosis, Treatment, Outcomes and Chronic Lymphocytic Leukemia Research.
- World rank
- #2,336,076 of 7,710,434 ranked researchers
- Rank in Iceland
- #895 of 2,050
- Works
- 37
- Citations
- 474
- Citations per work
- 12.8
What does Ingigerdur Solveig Sverrisdottir research?
Ingigerdur Solveig Sverrisdottir's work is mostly in Medicine (73%), Biochemistry, Genetics and Molecular Biology (19%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2772.7%
- Medicine2772.7%
- Life Sciences719.2%
- Everything else38.1%
- 1Hematology39% of their works
- 2Molecular Biology19% of their works
- 3Oncology15% of their works
- 4Genetics12% of their works
- 5Epidemiology3% of their works
- 6Surgery3% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Chronic Lymphocytic Leukemia Research
- Cancer Treatment and Pharmacology
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Peptidase Inhibition and Analysis
- Bone health and treatments
- Glycosylation and Glycoproteins Research
Which keywords describe Ingigerdur Solveig Sverrisdottir's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Cardiac Amyloidosis, Transthyretin, Chronic Lymphocytic Leukemia, Genomic Aberrations, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.
- Glycosylation
- Tumor Microenvironment
- Myelofibrosis
- Fibroblast Activation Protein
- Taxanes
- Genomic Aberrations
- Transthyretin
- International Myeloma Working Group
- Diagnosis Criteria
- Cardiac Amyloidosis
- Chronic Lymphocytic Leukemia
- Chemotherapy-Induced Peripheral Neuropathy
- Bisphosphonates
- JAK2 Mutation
- Osteonecrosis of the Jaw
- Glycans
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Diagnosis Criteria351 topic
- International Myeloma Working Group351 topic
- Cardiac Amyloidosis121 topic
- Transthyretin121 topic
- Chronic Lymphocytic Leukemia81 topic
- Genomic Aberrations81 topic
- Chemotherapy-Induced Peripheral Neuropathy71 topic
- Taxanes71 topic
- Bisphosphonates41 topic
- Fibroblast Activation Protein41 topic
- JAK2 Mutation41 topic
- Myelofibrosis41 topic
- Osteonecrosis of the Jaw41 topic
- Tumor Microenvironment41 topic
- Glycans31 topic
- Glycosylation31 topic
Where does Ingigerdur Solveig Sverrisdottir work?
Ingigerdur Solveig Sverrisdottir's main affiliation in the publication record is University of Iceland, Iceland.
How many publications and citations does Ingigerdur Solveig Sverrisdottir have?
OpenAlex counts 37 works and 474 citations for Ingigerdur Solveig Sverrisdottir, an h-index of 11, ranking #2,336,076 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ingigerdur Solveig Sverrisdottir. Posts are plain text and can be reported.